You are here

Home › Listings › Life Sciences › Algernon Pharmaceuticals Inc.

Algernon Pharmaceuticals Inc.

Listing Exchange: 
CSE
Status: 
Active
Industry: 
Life Sciences
Symbol: 
AGN
Associated Securities: 
Algernon Pharmaceuticals Inc. 27APRIL2023 Rights
CSE Index: 
Currency: 

Algernon Pharmaceuticals is a drug re-purposing company that investigates safe, already approved drugs for new disease applications, moving them efficiently and safely into new human trials, developing new formulations and seeking new regulatory approvals in global markets. Algernon specifically investigates compounds that have never been approved in the U.S. or Europe to avoid off label prescription writing.

You are here

Home

Algernon Pharmaceuticals Inc. (AGN)

SEDAR Information

Search form

Company Info

Address
Suite 1500 - 1055 West Georgia Street
Vancouver, BC V6E4N7
Canada
Phone
604-398-4175
Ext
701
Email
info@algernonpharmaceuticals.com
Website
http://algernonpharmaceuticals.com
Listing date
Monday, February 1, 2016
Transfer Agent
TSX Trust Company
Auditor
Smythe LLP

Capitalization

Issued & Outstanding: 
21640762
Reserved for Issuance: 
13662036

News Releases

11/04/2024

Algernon Pharmaceuticals CEO Christopher J. Moreau to Be Featured on Radius Research's Pitch, Deep Dive and Q&A Webinar on April 16th, 2024

02/04/2024

Algernon Pharmaceuticals to Move Forward with Psychedelic Drug DMT Stroke Research Program as its Lead Asset

Bulletins

21/04/2023

2023-0422 - Expiry - Algernon Pharmaceuticals Inc. - Rights (AGN.RT)

le 21 avril/April 2023

Algernon Pharmaceuticals Inc. Rights listed on March 28, 2023 will expire on April 27, 2023.

Settlement Terms: All trades April 25 and 26 will be for cash next day settlement. Trades on April 27 will be for cash same day.

The rights will be halted at noon and delisted at market close April 27, 2023.

___________________________

CSE Filings

Algernon - Mar 2024 Form 7 - Monthly Progress Report

Algernon Pharmaceuticals Inc. Material Change

Algernon Pharmaceuticals Inc. Form 10

Algernon Pharmaceuticals Inc. Form 6

Algernon Pharmaceuticals - Form 10 Notice of Proposed Significant Transaction